Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Willis, Tracey A ^a   Hollingsworth, Kieren G ^a   Coombs, Anna ^a   Sveen, Marie Louise ^b   Andersen, Søren ^b   Stojkovic, Tanya ^c   Eagle, Michelle ^a   Mayhew, Anna ^a   de Sousa, Paulo L ^d   Dewar, Liz ^e   Morrow, Jasper M ^e   Sinclair, Christopher D J ^e   Thornton, John S ^e   Bushby, Kate ^a   Lochmüller, Hanns ^a   Hanna, Michael G ^e   Hogrel, Jean Yves ^c   Carlier, Pierre G ^d   Vissing, John ^b   Straub, Volker ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Institute of Myology   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUKUTIN RELATED PROTEIN;

ADULT; ARTICLE; BICEPS FEMORIS LONG HEAD MUSCLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; DISEASE COURSE; DIXON TECHNIQUE; FEMALE; FOLLOW UP; FUKUTIN RELATED PROTEIN GENE; GASTROCNEMIUS MUSCLE; GENE; GENE MUTATION; GRACILIS MUSCLE; HAMSTRING; HOMOZYGOSITY; HUMAN; IMAGE ANALYSIS; LATERAL GASTROCNEMIUS MUSCLE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY 21; LONGITUDINAL STUDY; MALE; MEDIAL GASTROCNEMIUS MUSCLE; MULTICENTER STUDY; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; QUANTITATIVE FAT IMAGING; RECTUS FEMORIS MUSCLE; SARTORIUS MUSCLE; SEMIMEMBRANOSUS MUSCLE; SEMITENDINOUS MUSCLE; TERTIARY HEALTH CARE; VASTUS LATERALIS MUSCLE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; YOUNG ADULT;

EID: 84881527343     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070993     Document Type: Article

References (23)

1. Walter MC, Petersen JA, Stucka R, Fischer D, Schröder R, et al. (2004) FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet. 41: e50.
2. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, et al. (2001) Mutations in the fukutin related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet. 10: 2851-2859.
3. Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, et al. (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132: 3175-86.
4. Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, et al. (2003) The phenotype of limb girdle muscular dystrophy 2I. Neurology 60: 1246-51.
5. Bushby K, Beckmann JS, (2003) The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002. Neuromuscul Disord 13: 80-90.
6. Bushby K, Beckmann J, (1995) Diagnostic criteria for limb girdle muscular dystrophies:report of the ENMC workshop on limb girdle muscular dystrophies. Neuromuscul Disord 5: 71-74.
7. Wicklund M, Hilton-Jones D, (2003) The Limb Girdle Muscular Dystrophies. Genetic and phenotypic definition of a disputed entity. Neurology 60: 1230-31.
8. Mercuri E, Jungbluth H, Muntoni F, (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic imaging in inherited neuromuscular disorders. Curr Opin Neurol 18: 126-37.
9. Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, et al. (2007) Muscle MRI in inherited neuromuscular disorders: past, present and future. Journal of Magnetic Resonance Imaging 25: 433-440.
10. Lodi R, Muntoni F, Taylor J, Kumar S, Sewry CA, et al. (1997) Correlative MR Imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy. Neuromuscul Disord 7: 505-511.
11. Younkin D, Berman P, Sladky J, Chee C, Bank W, et al. (1987) 31P Nuclear magnetic resonance studies in Duchenne Muscular dystrophy: age related metabolic changes. Neurology 37: 165-9.
12. Sookhoo S, MacKinnon, Bushby K, Chinnery PF, Birchall D, (2007) MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clinical Radiology 62: 160-5.
13. Dixon W, (1984) Simple proton spectroscopic imaging. Radiology 153: 189-194.
14. van der Ploeg RJ, Fidler V, Oosterhuis HJ, (1991) Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 54: 244-247.
15. Mazzone ES, Messina S, Vasco G, Main M, Eagle M, et al. (2009) Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord 19: 458-61.
16. Podsiadlo D, Richardson S, (1991) The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39: 142-148.
17. Florence JM, van der Ploeg A, Clemens PR, Escolar DM, Laforet P, et al. (2008) Use of the 6 min walk test as an endpoint in clinical trials for neuromuscular diseases; Neuromuscul Disord. 18: 738-739.
18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117.
19. Coombs BD, Szumowski J, Coshow W, (1997) Two-point Dixon technique for water-fat signal decomposition with B0 inhomogeneity correction. Magn Reson Med 38: 884-889.
20. Glover GH, Schneider E, (1991) Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 18: 371-383.
21. Mercuri E, Pichiecchio A, Counsell S, Allsop J, Cini C, et al. (2002) A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 6: 305-307.
22. Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, et al. (2002) Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p(RSMD1). Neuromuscul Disord 12: 631-638.
23. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327: 307-310.